Head-to-head · WeighScore
Blue Sky MD vs HealthRX
By GLP-1 ScorecardUpdated
Score comparison
HealthRX has the higher recorded score — 77.5/100 to 67.7/100.
HealthRX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. HealthRX advertises a $39 first month on three-, six- and twelve-month injection plans, with a higher month-to-month option; a plan's remaining monthly payments stay due if you cancel early.
Before you choose
Blue Sky MD does not publish a semaglutide price, so its Blue Sky MD review sets out what it does disclose, while the HealthRX review explains the conditions attached to HealthRX's figure. The semaglutide cost page compares published rates across the field. Ask Blue Sky MD for a written total before treating either one as the cheaper choice.
If neither one fits, Blue Sky MD vs Invigor Medical and Brello Health vs HealthRX compare each of them with another graded program, and the list of alternatives to Blue Sky MD ranks the programs closest to Blue Sky MD on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Blue Sky MD | HealthRX |
|---|---|---|
| WeighScore | 67.7/100 | 77.5/100 |
| Grade | C | C+ |
| Site position | #172 | #34 |
| Semaglutide | Not disclosed | $39 first month, then $125/month on a 3-month plan ($115 on 6 months, $97 on 12); month to month $109 first month, then $139/month |
| Tirzepatide | Not disclosed | $39 first month, then $219/month on a 3-month plan ($179 on 6 months, $159 on 12); month to month $109 first month, then $239/month |
| Coverage | North Carolina program; confirm eligibility for telehealth | All 50 states claimed; subject to clinical eligibility |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Strengths
- Free initial health assessment advertised
- Program describes supervised prescribing, labs and coaching
- Offers clinic and telehealth visits and says it can help verify benefits
What to consider
- No medication-specific charge confirmed on the public program page
- Coverage for visits does not establish coverage for a prescription
- Confirm what tests are billed and where the prescription will be filled
Strengths
- First payment and recurring monthly charge shown together for every plan
- Medication if prescribed, review, instructions and overnight shipping included; no separate GLP-1 membership fee stated
- A month-to-month option carries no minimum term
- Full refund promised if clinical approval is declined
What to consider
- On 3-, 6- and 12-month plans the remaining monthly payments stay due after an early cancellation
- Assigned medical practice and dispensing pharmacy not named on reviewed public pages
- Refund promises for unshipped doses need reconciliation with restrictions after dispensing
- Injection supplies, clinical response time and monitoring cadence unconfirmed
Featured provider
HealthRX
Factor scores not reassessed.HealthRX scores 77.5/100 (C+). HealthRX advertises a $39 first month on three-, six- and twelve-month injection plans, with a higher month-to-month option; a plan's remaining monthly payments stay due if you cancel early.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.